tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AbCellera Biologics Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsAbCellera Biologics Reports Q3 2025 Financial Results
27d ago
AbCellera Biologics Reports Q3 2025 Financial Results
Premium
Company Announcements
AbCellera Biologics Reports Q3 2025 Financial Results
28d ago
AbCellera reports Q3 EPS (19c), consensus (16c)
Premium
The Fly
AbCellera reports Q3 EPS (19c), consensus (16c)
28d ago
AbCellera doses first participants in Phase 1 trial of ABCL575
PremiumThe FlyAbCellera doses first participants in Phase 1 trial of ABCL575
3M ago
AbCellera Biologics Earnings Call: Clinical Progress and Financial Insights
Premium
Company Announcements
AbCellera Biologics Earnings Call: Clinical Progress and Financial Insights
4M ago
AbCellera price target raised to $7 from $5 at BMO Capital
Premium
The Fly
AbCellera price target raised to $7 from $5 at BMO Capital
4M ago
AbCellera assumed with an Outperform at Leerink
PremiumThe FlyAbCellera assumed with an Outperform at Leerink
5M ago
AbCellera Biologics Holds Annual Shareholder Meeting
Premium
Company Announcements
AbCellera Biologics Holds Annual Shareholder Meeting
6M ago
Unusually active option classes on open June 11th
Premium
The Fly
Unusually active option classes on open June 11th
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100